[Federal Register Volume 65, Number 166 (Friday, August 25, 2000)]
[Notices]
[Pages 51812-51813]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-21796]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Anthrax Vaccine

AGENCY: U.S. Army Medical Research and Materiel Command, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

[[Page 51813]]

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent Application Serial Number 09/
350,755 entitled ``Anthrax Vaccine'', filed July 9, 1999. Foreign 
rights are also available. This patent application has been assigned to 
the United States Government as represented by the Secretary of the 
Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Office of the Staff Judge Advocate, MCMR-JA, 504 Scott Street, 
Fort Detrick, Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to vaccines for 
bacterial toxins from Bacillus anthracis. The invention relates to a 
method and composition for use in inducing an immune response which is 
protective against infection with anthrax.

Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 00-21796 Filed 8-24-00; 8:45 am]
BILLING CODE 3710-08-U